Traders Sell UnitedHealth Group Incorporated (UNH) on Strength on Insider Selling

Traders sold shares of UnitedHealth Group Incorporated (NYSE:UNH) on strength during trading hours on Thursday following insider selling activity. $81.70 million flowed into the stock on the tick-up and $116.96 million flowed out of the stock on the tick-down, for a money net flow of $35.26 million out of the stock. Of all equities tracked, UnitedHealth Group had the 25th highest net out-flow for the day. UnitedHealth Group traded up $1.27 for the day and closed at $211.13Specifically, insider Thomas E. Roos sold 975 shares of the firm’s stock in a transaction that occurred on Thursday, October 19th. The stock was sold at an average price of $205.47, for a total value of $200,333.25. Following the completion of the sale, the insider now directly owns 24,630 shares of the company’s stock, valued at $5,060,726.10. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Larry C. Renfro sold 50,574 shares of the firm’s stock in a transaction that occurred on Friday, September 15th. The shares were sold at an average price of $198.11, for a total value of $10,019,215.14. Following the completion of the sale, the insider now directly owns 195,625 shares of the company’s stock, valued at $38,755,268.75. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 72,606 shares of company stock valued at $14,308,783. Insiders own 0.89% of the company’s stock.

Several analysts recently weighed in on the company. Barclays PLC lifted their price target on UnitedHealth Group from $200.00 to $217.00 and gave the stock an “overweight” rating in a report on Wednesday, July 19th. Leerink Swann reissued a “buy” rating and set a $240.00 price target (up from $225.00) on shares of UnitedHealth Group in a report on Wednesday, October 18th. Zacks Investment Research raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $219.00 price target for the company in a report on Thursday, September 21st. Cantor Fitzgerald lifted their price target on UnitedHealth Group to $225.00 and gave the stock an “overweight” rating in a report on Wednesday, October 18th. Finally, Oppenheimer Holdings, Inc. lifted their price target on UnitedHealth Group from $215.00 to $205.00 and gave the stock an “outperform” rating in a report on Wednesday, October 18th. Three analysts have rated the stock with a hold rating and twenty-four have issued a buy rating to the company. UnitedHealth Group presently has a consensus rating of “Buy” and a consensus target price of $216.65.

The stock has a market cap of $204,130.00, a P/E ratio of 22.05, a PEG ratio of 1.57 and a beta of 0.64. The company has a debt-to-equity ratio of 0.52, a quick ratio of 0.70 and a current ratio of 0.70.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Tuesday, October 17th. The healthcare conglomerate reported $2.66 earnings per share for the quarter, topping analysts’ consensus estimates of $2.57 by $0.09. The business had revenue of $50.32 billion for the quarter, compared to analyst estimates of $50.38 billion. UnitedHealth Group had a return on equity of 21.52% and a net margin of 4.50%. UnitedHealth Group’s quarterly revenue was up 8.7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $2.17 EPS. sell-side analysts forecast that UnitedHealth Group Incorporated will post 9.99 earnings per share for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 12th. Investors of record on Friday, December 1st will be given a dividend of $0.75 per share. The ex-dividend date is Thursday, November 30th. This represents a $3.00 dividend on an annualized basis and a yield of 1.43%. UnitedHealth Group’s dividend payout ratio is currently 34.09%.

A number of hedge funds have recently modified their holdings of the stock. Regal Wealth Group Inc. grew its position in UnitedHealth Group by 0.4% during the 2nd quarter. Regal Wealth Group Inc. now owns 746 shares of the healthcare conglomerate’s stock worth $138,000 after acquiring an additional 3 shares during the last quarter. Jackson Grant Investment Advisers Inc. grew its position in UnitedHealth Group by 0.4% during the 2nd quarter. Jackson Grant Investment Advisers Inc. now owns 1,101 shares of the healthcare conglomerate’s stock worth $204,000 after acquiring an additional 4 shares during the last quarter. RB Capital Management LLC grew its position in UnitedHealth Group by 0.4% during the 2nd quarter. RB Capital Management LLC now owns 1,732 shares of the healthcare conglomerate’s stock worth $321,000 after acquiring an additional 7 shares during the last quarter. Altfest L J & Co. Inc. grew its position in UnitedHealth Group by 0.3% during the 2nd quarter. Altfest L J & Co. Inc. now owns 2,963 shares of the healthcare conglomerate’s stock worth $549,000 after acquiring an additional 10 shares during the last quarter. Finally, Parkside Financial Bank & Trust grew its position in UnitedHealth Group by 1.4% during the 1st quarter. Parkside Financial Bank & Trust now owns 854 shares of the healthcare conglomerate’s stock worth $140,000 after acquiring an additional 12 shares during the last quarter. Institutional investors and hedge funds own 86.00% of the company’s stock.

TRADEMARK VIOLATION WARNING: “Traders Sell UnitedHealth Group Incorporated (UNH) on Strength on Insider Selling” was first posted by The Ledger Gazette and is owned by of The Ledger Gazette. If you are reading this piece on another domain, it was stolen and reposted in violation of U.S. and international trademark and copyright law. The original version of this piece can be read at https://ledgergazette.com/2017/11/16/traders-sell-unitedhealth-group-incorporated-unh-on-strength-on-insider-selling.html.

About UnitedHealth Group

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply